Urinary Incontinence - PowerPoint PPT Presentation

About This Presentation
Title:

Urinary Incontinence

Description:

Urinary Incontinence Abdallah Rimawi, MD Geriatrics Fellow SVCMC Definition Involuntary loss of urine in a sufficient amount or frequency to be a social/health problem. – PowerPoint PPT presentation

Number of Views:2238
Avg rating:3.0/5.0
Slides: 58
Provided by: joshcorwi6
Category:

less

Transcript and Presenter's Notes

Title: Urinary Incontinence


1
Urinary Incontinence
  • Abdallah Rimawi, MD
  • Geriatrics Fellow
  • SVCMC

2
Definition
  • Involuntary loss of urine in a sufficient amount
    or frequency to be a social/health problem.

3
Epidemiology
  • UI has a prevalence
  • 15-30 in community-residing elderly patients
  • 50-84 among older adults in long-term care
    institutions
  • 33 in older persons in acute care settings.
  • UI affects more than 17 million Americans, 85 of
    whom are women.
  • Estimated cost to society of 16 to 26 billion.
  • Race No clear evidence of racial differences in
    prevalence of UI has been found.
  • UI is approximately twice as prevalent in older
    women as in older men, with 20 being women older
    than 45 years. In some women, stress incontinence
    and urge incontinence, the two most common forms
    of UI, may coexist.

4
Epidimiology
  • Urge incontinence constitutes over 50 of
    overall incontinence in men, 10-15 in younger
    women, and 30-40 in older women. Stress
    incontinence tends to be more common in women
    younger than 65 years.

5
Stress vs Urge
  • Distribution of different types of incontinence
    in the general population. Diagnoses other than
    stress, urge, and mixed are excluded.
  • Dr. Hogne Sandvik 1996 nobel award in biology

6
Prevalence of Stress vs Urge
7
Prevalence in Females
8
(No Transcript)
9
Normal micturition
  • The normal function of the urinary bladder is to
    store and expel urine in a coordinated,
    controlled fashion. This coordinated activity is
    regulated by the central and peripheral nervous
    systems

10
Normal Urination
  • The process of urination involves two phases
  • 1) The filling and storage phase
  • 2) The emptying phase

11
(No Transcript)
12
Filling Phase
  • Filling/ storage phase Under Sympathetic
    control
  • the bladder begins to fill with urine from the
    kidneys. The bladder stretches to accommodate the
    increasing amounts of urine. No increase in
    pressure Sympathetic system relaxes Detrusor
    muscle
  • Sympathetic system closes bladder neck by
    constricting internal urethral sphincter
  • The first sensation of the urge to urinate occurs
    when approximately 200 ml (just under 1 cup) of
    urine is stored. A healthy nervous system will
    respond to this stretching sensation by alerting
    you to the urge to urinate, while also allowing
    the bladder to continue to fill.
  • The average person can hold approximately 350 to
    550 ml of urine. The ability to fill and store
    urine properly requires a functional sphincter
    (the circular muscles around the opening of the
    bladder) and a stable, expandable bladder wall
    muscle (detrusor).
  • The filling of the urinary bladder depends on the
    intrinsic viscoelastic properties of the bladder
    and the inhibition of the parasympathetic nerves.
    Thus, bladder filling primarily is a passive
    event.
  • Sympathetic nerves also facilitate urine storage
    in the following ways
  • Sympathetic nerves inhibit the parasympathetic
    nerves from triggering bladder contractions.
  • Sympathetic nerves directly cause relaxation and
    expansion of the detrusor muscle.
  • Sympathetic nerves close the bladder neck by
    constricting the internal urethral sphincter.
    This sympathetic input to the lower urinary tract
    is constantly active during bladder filling.
  • As the bladder fills, the pudendal nerve becomes
    excited. Stimulation of the pudendal nerve
    results in contraction of the external urethral
    sphincter. Contraction of the external sphincter,
    coupled with that of the internal sphincter,
    maintains urethral pressure (resistance) higher
    than normal bladder pressure. The combination of
    both urinary sphincters is known as the
    continence mechanism.
  • The pressure gradients within the bladder and
    urethra play an important functional role in
    normal micturition. As long as the urethral
    pressure is higher than that of the bladder,
    patients will remain continent. If the urethral
    pressure is abnormally low or if the intravesical
    pressure is abnormally high, urinary incontinence
    will result.
  • As the bladder initially fills, a small rise in
    pressure occurs within the bladder (intravesical
    pressure). When the urethral sphincter is closed,
    the pressure inside the urethra (intraurethral
    pressure) is higher than the pressure within the
    bladder. While the intraurethral pressure is
    higher than the intravesical pressure, urinary
    continence is maintained.
  • During some physical activities and with
    coughing, sneezing, or laughing, the pressure
    within the abdomen rises sharply. This rise is
    transmitted to both the bladder and urethra. As
    long as the pressure is evenly transmitted to
    both the bladder and urethra, urine will not
    leak. When the pressure transmitted to the
    bladder is greater than urethra, urine will leak
    out, resulting in stress incontinence.

13
Emptying Phase
  • Emptying phase requires the ability of the
    detrusor muscle to appropriately contract to
    force urine out of the bladder. At the same time,
    your body must be able to relax the sphincter to
    allow the urine to pass out of the body.

14
Normal micturition cycle
15
Central Control
  • Brain
  • The brain is the master control of the entire
    urinary system.
  • The micturition control center is located in the
    frontal lobe.
  • Sends inhibitory signals to the detrusor muscle
    Via the Pons and spine to prevent the bladder
    from emptying (contracting) until a socially
    acceptable time and place to urinate is
    available.
  • Certain lesions or diseases of the brain,
    including stroke, cancer, or dementia, result in
    loss of control of the normal micturition reflex.
  • The signal transmitted by the brain is routed
    through 2 intermediate stops (the brainstem and
    the sacral spinal cord) prior to reaching the
    bladder.

16
Brain ? Pons
  • PONS
  • Pons a major relay center between the brain and
    the bladder.
  • Contains the pontine micturition center (PMC)
    which coordinates the urethral sphincter
    relaxation and detrusor contraction to facilitate
    urination.
  • The PMC is Exitatory in nature and causes
    urination unless inhibited by the brain.
  • The PMC functions as a relay switch in
    the voiding pathway. Stimulation of the PMC
    causes the urethral sphincters to open while
    facilitating the detrusor to contract and expel
    the urine.
  • Usually the brain takes over the control of the
    pons at age 3-4 years, which is why most children
    undergo toilet training at this age.

17
Sequence of normal events
  • When Bladder becomes full, the stretch
    receptors of the detrusor muscle send a signal to
    the pons (via the spinal cord), which in turn
    notifies the brain. Patients perceive this signal
    (bladder fullness) as a sudden desire to go to
    the bathroom. Under normal situations, the brain
    sends an inhibitory signal to the pons to inhibit
    the bladder from contracting until a bathroom is
    found.
  • When the PMC is deactivated, the urge to urinate
    disappears, allowing the patient to delay
    urination until locating a suitable bathroom.
    When urination is appropriate, the brain sends
    excitatory signals to the pons, allowing the
    urinary sphincters to open and the detrusor to
    empty.

18
Brain ? Pons ?Spinal cord
  • Spinal cord
  • The spinal cord connects the brainstem and the
    lumbosacral spine.
  • The spinal cord functions as a long communication
    pathway between the brainstem and the sacral
    spinal cord. When the sacral cord receives the
    sensory information from the bladder, this signal
    travels up the spinal cord to the pons and then
    ultimately to the brain. The brain interprets
    this signal and sends a reply via the pons that
    travels down the spinal cord to the sacral cord
    where the bladder receives it.

19
Spinal cord Trauma
  • An intact spinal cord is critical for normal
    micturition. If the spinal cord is severely
    injured or severed, the affected individual will
    exhibit constant urinary leakage because of
    uncontrollable bladder spasms, a condition called
    detrusor hyperreflexia.
  • If complete spinal cord transection has occurred,
    the patient will demonstrate symptoms of urinary
    frequency, urgency, and urge incontinence but
    will be unable to empty his or her bladder
    completely. This occurs because the urinary
    bladder and the sphincter are both overactive, a
    condition termed detrusor sphincter dyssynergia
    with detrusor hyperreflexia

20
Sacral spinal cord
  • The sacral spinal cord is the terminal portion of
    the spinal cord at the lower back in the lumbar
    area. This is a specialized area of the spinal
    cord known as the sacral reflex center. It is
    responsible for bladder contractions. The sacral
    reflex center is the primitive voiding center.
  • If the sacral cord becomes severely injured (eg,
    spinal tumor, herniated disc), the bladder may
    not function. Affected patients may develop
    urinary retention, termed detrusor areflexia. The
    detrusor will be unable to contract, so the
    patient will not be able to urinate and urinary
    retention will occur.

21
Physiology PNS
  • Sympathetic system (Epinepherine
    Norepinepherine)
  • Normally controls the bladder and internal
    urethral sphincter
  • Accommodation an increase the bladder
    capacity without raising bladder pressure
  • Keeps the internal urinary sphincter
    tightly closed.
  • relaxes bladder dome
  • inhibits parasympathetic system
  • The sympathetic activity also inhibits the
    micturition reflex is inhibited.

22
Parasympathetic
  • The parasympathetic nervous system functions in
    a manner opposite to that of the sympathetic
    nervous system
  • stimulates the detrusor muscle to contract the
    bladder
  • Causes internal and external urethral sphincter
    relaxation and opening
  • Inhibits the pudendal nerve which opens the
    external sphincter
  • Causes initiation of micturition and emptying of
    the urinary bladder

23
Somatic
  • Regulates action of voluntary muscles
  • Contraction of external urethral sphincter

The somatic nervous system regulates the
actions of the muscles under voluntary control.
Such as muscles of the external urinary sphincter
and the pelvic diaphragm. .
suprasacral-infrapontine spinal cord trauma can
cause overstimulation of the pudendal nerve that
results in urinary retention.
24
(No Transcript)
25
Urinary Incontinence
26
Requirements for storage
  • Accomodation increase in volume with decrease
    in pressure
  • Closed outlet
  • Appropriate sensation of fullness
  • Absence of involuntary bladder contractions

27
Requirements for emptying
  • Good contractility
  • Lack of anatomic obstruction
  • Coordination of bladder and outlet

28
Requirements for continence
  • Mobility
  • Manual dexterity
  • Cognitive ability to recognize and react to
    bladder filling
  • The motivation to stay dry

29
Sudden/Temporary incontinence etiology
  • Urinary tract infection or prostate
    infection/inflammation
  • Stool impaction causing pressure on the bladder
  • Side effects of medications (such as diuretics,
    tranquilizers, some cough and cold remedies,
    certain antihistamines for allergies, and
    antidepressants)
  • Polyurea due to poorly controlled diabetes
  • Pregnancy
  • Short-term bedrest -- for example, when
    recovering from surgery
  • Mental confusion
  • Usually reversable once treated or removed

30
Long term incontinence
  • Spinal injuries
  • Urinary tract anatomical abnormalities
  • Neurological conditions like multiple sclerosis
    or stroke
  • Weakness of the sphincter, the circular muscles
    of the bladder responsible for opening and
    closing it this can happen following prostate
    surgery in men, or vaginal surgery in women
  • Pelvic prolapse in women -- falling or sliding of
    the bladder, urethra, or rectum into the vaginal
    space, often related to having had multiple
    pregnancies and deliveries
  • Large prostate in men
  • Depression or Alzheimers disease
  • Nerve or muscle damage after pelvic radiation
  • Bladder cancer
  • Bladder spasms

31
Types of Urinary Incontinence
  • Stress incontinence - loss of urine with
    increased intraabdominal pressure without
    detrusor contraction. Most common form of UI in
    women
  • Urge incontinence - (true, detrusor overactivity,
    or reflex) is precipitous loss of urine, preceded
    by a strong urge to void, with increased
    intravesical pressure and detrusor contraction.
  • Continuous incontinence - is involuntary loss of
    urine at all times and in all positions.
  • Overflow incontinence - results from detrusor
    underactivity, bladder outlet obstruction, or
    both. Leakage is small in volume but continual.
    In men, it can be the result of an enlarged
    prostate.

32
Stress incontinence
  • Stress incontinence is an involuntary loss of
    urine that occurs during physical activity, such
    as coughing, sneezing, laughing, or exercise.
  • Stress incontinence is a bladder storage problem
    in which the strength of the urethral sphincter
    is diminished, and the sphincter is not able to
    prevent urine flow when there is increased
    pressure from the abdomen.
  • Stress incontinence may occur as a result of
    weakened pelvic muscles that support the bladder
    and urethra, or because of malfunction of the
    urethral sphincter. Prior trauma to the urethral
    area, neurological injury, and some medications
    may weaken the urethra. Stress incontinence can
    worsen during the week before your menstrual
    period. At that time, lowered estrogen levels
    might lead to lower muscular pressure around the
    urethra, increasing chances of leakage. The
    incidence of stress incontinence increases
    following menopause.

33
Stress incontinence
  • Sphincter weakness may occur in men following
    prostate surgery or in women after pelvic
    surgery. Stress incontinence is often seen in
    women who have had multiple pregnancies and
    vaginal childbirths, or who have pelvic prolapse
    (protrusion of the bladder, urethra, or rectal
    wall into the vaginal space), with cystocele,
    cystourethrocele, or rectocele.
  • Studies have documented that about 50 of all
    women have occasional urinary incontinence, and
    as many as 10 have frequent incontinence. Nearly
    20 of women over age 75 experience daily urinary
    incontinence.
  • Stress urinary incontinence is the most common
    type of urinary incontinence in women. Risk
    factors for stress incontinence include female
    sex, advancing age, childbirth, smoking, and
    obesity. Conditions that cause chronic coughing,
    such as chronic bronchitis and asthma, may also
    increase the risk of stress incontinence.

34
Stress incontinence treatment
  • Goal of nonsurgical treatment is to increase
    internal sphincter tone. Mild to moderate stress
    incontinence may be effectively treated with
    exercise therapy, medications, or both.
  • The most common cause of stress incontinence in
    older women is urethral hypermobility In up to
    60 of women with stress incontinence, pelvic
    floor (Kegel) exercises can result in better
    control of the bladder when coughing, laughing,
    sneezing, or exercising.1 These exercises should
    be performed 10-20 times, 3 times a day
  • Medication may be used to tighten the bladder and
    prevent urine leakage, but its effectiveness
    varies.
  • Electrical stimulation can be used to reduce both
    stress incontinence and urge incontinence

35
Treatment stress incontinence
  • Surgical intervention
  • Surgery elevates the bladder neck and brings the
    proximal urethra back into the abdomen the
    1-year success rate is 80-95. Surgery to add
    support for the bladder neck is usually needed
    for severe stress incontinence that does not
    respond to medication or exercise.

36
Treatment stress incontinence
  • Medications
  • Alpha-adrenergic agonists (pseudoephedrine) are
    used especially for women on estrogen they
    increase the internal sphincter tone and bladder
    outflow resistance. Use with caution in patients
    with hypertension or arrhythmia.
  • Estrogen cream to the vagina or oral estrogen
    tablets may be helpful in improving
    periurethral and vaginal tissue thickness and
    quality.
  • Treat precipitating conditions (atrophic
    vaginitis, cough).
  • Incontinence pads may be used to absorb the small
    amount of urine that usually leaks during stress.

37
Urge incontinence
  • Alternate Names Detrusor Hyperreflexia,
    Detrusor Instability, Overactive Bladder,
    Spasmodic Bladder, Unstable Bladder
  • Bladder muscle contracts inappropriately,
    regardless of the amount of urine that is in the
    bladder.
  • Population May occur in anyone at any age, but
    it is more common in women and elderly. Second
    only to stress incontinence as the most common
    cause of urinary incontinence (involuntary loss
    of urine). Approximately 1 to 2 of adult
    females are affected by urge incontinence.
  • In men, urge incontinence may be due to secondary
    bladder injuries caused by benign prostatic
  • Mechanism
  • PVC "Premature Vesicular Contraction"
  • Overly sensitive bladder Urge to void is
    perceived
  • Inhibition of detrussor contraction is
    ineffective

38
Etiology urge incontinence
  • Etiologies Urge incontinence may result from
    neurological injuries (such as spinal cord injury
    or stroke), neurological diseases (such as
    multiple sclerosis), infection, bladder cancer,
    bladder stones, bladder inflammation, or bladder
    outlet obstruction.
  • The majority of cases are classified as
    idiopathic -- a specific cause cannot be
    identified
  • Signs and Symptoms
  • Irresistable urge to void
  • Urge preceeded by various stimulation
    Posture change, Hear or feel water ,Laugh or
    cough
  • Urine volume lost Few drops to entire
    bladder contents
  • Urine loss timingBegins seconds after
    trigger

39
Urge incontinence
  • Diagnostics
  • Rule out neurological or infectious etiology
  • Sterile in-out catheterization or
  • Ultrasound measurement of post-void residual

40
Urge incontinence treatment
  • Treat symptomatically if no known cause
  • Pelvic Muscle Rehabilitation improves muscle
    tone and prevent urine leakage.
  • Daily Kegel exercises (contracting and relaxing
    the pelvic floor muscles)
  • Biofeedback
  • Vaginal weight training Small weights are held
    within the vagina by tightening the vaginal
    muscles.
  • Pelvic floor or nerve electrical stimulation.
    Mild, painless electrical impulses are used to
    stimulate the pelvic muscles and/or nerves to
    help relieve the symptoms of overactive bladder
    and urge incontinence.
  • Behavioral Therapies
  • Bladder training teaches people how to resist the
    urge to urinate.
  • Toileting assistance uses routine or scheduled
    toileting and prompted voiding to empty the
    bladder regularly to prevent leaking.
  • Surgery
  • Surgical procedures of the bladder may be
    performed for people who do not respond to any
    other treatment

41
Treatment urge incontinence
  • Medication aimed at relaxing the involuntary
    contraction of the bladder and improving bladder
    function
  • anticholinergic agents (propantheline)
  • antispasmodic medications (oxybutynin,
    tolterodine, flavoxate)
  • tricyclic antidepressants (imipramine, doxepin)
  • calcium channel blockers (tolterodine)
  • beta agonist (terbutaline)
  • Oxybutynin (Ditropan) and tolterodine (Detrol)
    antispasmodic medications that relax the smooth
    muscle of the bladder. These are the most
    commonly used medications for urge incontinence
  • Side effects of oxybutynin and tolterodine are
    minimal, with the most common being dry mouth and
    constipation. However, these medications cannot
    be used by patients with narrow angle glaucoma.
  • Anticholinergic medications block inappropriate
    contractions of the bladder. They were widely
    used in the past to treat urge incontinence
    because they are relatively inexpensive yet
    effective. Oxybutynin and tolterodine have
    virtually replaced the use of these medications
    because they have fewer side effects.
  • Tricyclic antidepressants have also been used to
    treat urge incontinence because of their ability
    to inhibit or "paralyze" the bladder smooth
    muscle. Possible side effects include fatigue,
    dry mouth, dizziness, blurred vision, nausea and
    insomnia

42
Overflow incontinence
  • Overflow Incontinence Overflow incontinence is
    the uncontrollable leakage of small amounts of
    urine, usually caused by some type of blockage or
    by weak contractions of the bladder muscles. When
    urine flow is blocked or the bladder muscles can
    no longer contract, the bladder becomes
    overfilled and enlarged. Pressure in the bladder
    increases until small amounts of urine dribble
    out.
  • In men, an enlarged prostate can block the
    opening into the urethra from the bladder. Less
    commonly, blockage is caused by narrowing of the
    bladder neck or the urethra (urethral stricture),
    which may occur after prostate surgery. In men
    and women, constipation can cause overflow
    incontinence if stool fills the rectum to the
    point of putting pressure on the bladder neck and
    urethra. A number of drugs that affect the brain
    or spinal cord or that interfere with nerve
    messages, such as anticholinergic drugs and
    opioids, may impair bladder contractions and
    cause overflow incontinence. Nerve damage that
    paralyzes the bladder (neurogenic bladder) can
    also cause overflow incontinence. Diabetes
    mellitus can also cause a form of neurogenic
    bladder and overflow incontinence.

43
Overflow S/S
  • Signs and Symptoms
  • Palpable distended bladder post voiding
  • Post-void residual gt200 cc
  • Have patient void
  • Insert Urinary Catheter and record urine volume
  • Normally less than 50 cc

44
Overflow Diagnosis and management
  • Diagnosis Ultrasound assess bladder volume
  • Uroflowmetry (urodynamics)
  • Management General
  • Correct underlying outflow obstruction
  • Intermittent Self Catheterization
  • Double Voiding
  • Crede's Maneuver

45
Overflow medications
  • Medical Management
  • 1) Betanachol (Urecholine)
  • Mechanism
  • Cholinergic agonist with Parasympathetic
    stimulation contracts detrussor
  • Indications Non-obstructive bladder
    atony
  • Contraindications Hyperthyroidism ,
    Peptic Ulcer Disease , Asthma
  • 2) Alpha-Adrenergic blockade
  • Prazosin (Minipress) ,Terazosin (Hytrin)
  • Mechanism
  • Decreases bladder neck and urethral tone
  • Indications Benign Prostatic
    Hypertrophy ,Sphincter Hyperspasticity

46
Overflow Outlet obstruction
  • These patients have difficulty emptying their
    bladders therefore, the goal is to improve
    bladder drainage. Follow conservative management
    by modifying fluid excretion and prompted
    voiding.
  • Do a renal sono to find cause and proceed
  • Medications include alpha-adrenergic antagonists
    prazosin decreases internal sphincter tone and
    can improve the flow of urine. Use antiandrogens
    and luteinizing hormone-releasing hormone (LHRH)
    analog if atonic bladder-cholinergics (eg,
    bethanechol) are ineffective in treating UI.
  • Self-catheterization or a Foley catheter is used,
    especially in cases of neurogenic bladder.
  • Urethral strictures may require dilation or
    surgery, especially if the prostate is enlarged.

47
Overflow Underactive detrusor
  • Initial goals are to reduce residual volume,
    eliminate hydronephrosis, and prevent urosepsis.
    Insert an indwelling or intermittent catheter to
    decompress the bladder (for 2 wk).
  • Identify and reverse potential causes of impaired
    detrusor function (eg, fecal impaction,
    medications).

48
Female Pelvic muscles
49
Types of UI
  • Intense urge to void Detrusor overactivity/Urge
    incontinence
  • Loss with cough/laugh/bending stress
    incontinence
  • Continuous leakage Detrusor underactivity/overflo
    w incontinence

50
History
  • Obtaining a thorough history is the most
    important step in the evaluation of UI.
  • Onset
  • During pregnancy
  • Postpartum
  • Surgery or trauma
  • Frequency/severity/amount
  • Number of pads
  • Voiding diary
  • A small amount of urine usually is seen in
    overflow incontinence or outlet incompetence, and
    moderate flow in detrusor overactivity.
  • Patterns (eg, nocturnal versus diurnal)
  • Precipitants
  • Medications
  • Cough
  • Position changes

51
History cont
  • Associated symptoms
  • Straining
  • Incomplete emptying
  • Dysuria
  • Medical conditions
  • Cancer
  • Diabetes
  • Neurologic disease
  • Surgeries
  • Radiation
  • Benign prostatic hyperplasia
  • UTI
  • Prolonged labor
  • Trauma
  • Hypertension
  • Congestive heart failure (CHF)
  • Medications (eg, anticholinergics, calcium
    channel blockers, diuretics, sedatives,
    alpha-agonists, alpha-antagonists, alcohol)
  • Living conditions

52
Physical
  • Carry out a thorough examination, including a
    brief psychiatric and neurologic evaluation.
    Eliminate any serious disease that may be the
    underlying cause of incontinence and any
    transient cause or functional impairment.
  • Assess the abdomen, looking at flanks check for
    masses, distended bladder after voiding, and
    signs of fluid overload.
  • Neurologic
  • Check for perineal sensation and fecal impaction.
    Check bulbocavernous reflex, anal sphincter tone,
    and prostate.
  • Absence of an anal wink is not necessarily
    pathologic in elderly patients.
  • Pelvic
  • A pelvic examination is necessary for women the
    examination should be made with the patient's
    bladder empty to check organs and with the
    bladder full to check for prolapse, cystocele,
    rectocele, or incontinence.
  • Rotate the speculum to evaluate the anterior and
    posterior vaginal walls.
  • Look for atrophic vaginitis, masses, muscle
    laxity, and cystocele.
  • Internal sphincter weakness can be assessed by
    asking the patient to cough while supine leakage
    of urine is suggestive of outlet incompetence.

53
Physical cont
  • Q-Tip test
  • This is used to evaluate urethral mobility
    hypermobility can lead to stress incontinence.
  • Perform this test by inserting a cotton swab
    through the urethra into the bladder and note any
    changes in the angle of the swab with the patient
    straining.
  • A change of 30-40 suggests excessive urethral
    movement.
  • The Q-Tip test has been found to have a high
    false-negative rate in elderly women.
  • Stress testing
  • Stress testing assesses for stress-induced
    leakage when the bladder is full.
  • Stress testing is performed by having the patient
    relax and asking the patient to cough or strain
    once vigorously instantaneous leakage is typical
    of stress urinary incontinence, delayed leakage
    is typical of stress-induced detrusor
    overactivity.
  • This test, if performed correctly, is greater
    than 90 sensitive and specific.

54
Diagnosis
  • UA, urine culture to look for infection, and
    serum electrolytes, including calcium
  • Blood glucose
  • PSA
  • Postvoid residual urine volume
  • Postvoid residual (PVR) urine volume is assessed
    by catheterizing and measuring residual urine
    within 5 minutes after voiding.
  • PVR greater than 50 mL may indicate obstruction
    of hypotonic bladder.
  • PVR greater than 400 mL is likely overflow
    incontinence.
  • Renal Sono
  • Urodynamic studies
  • Cystometry

55
Treatment
56
References
  • http//www.nlm.nih.gov/medlineplus/ency/article/00
    3142.htm
  • http//www.emedicine.com/emerg/topic791.htm
  • http//www.americangeriatrics.org/products/ui/inco
    n5.m.htm
  • http//www.familydoctor.co.uk/htdocs/FEMALEURINE/F
    EMALEURINE_specimen.html
  • http//www.netterimages.com/womenshealth/image8.ht
    m
  • http//www.medscape.com/viewprogram/2666_pnt
  • http//www.irishhealth.com/?level4id117
  • http//jaapa.com/issues/j20051001/articles/urinary
    1005.htm

57
Thank You
Write a Comment
User Comments (0)
About PowerShow.com